Skip to main content
. Author manuscript; available in PMC: 2023 Jul 27.
Published in final edited form as: Eur Heart J Acute Cardiovasc Care. 2017 Jul 10;8(1):68–77. doi: 10.1177/2048872617710790

Table 4. Excess mortality and observed all-cause mortality using imputed data (full model).

Full model EMRR MRR
Age by follow-up interaction
≤55 years (reference) 1.00 1.00
Up to 4 years post primary PCI
Age 56–65 1.61 (1.46–1.79)a 1.73 (1.57–1.90) a
Age 66–75 2.49 (2.26–2.75) a 2.96 (2.71–3.23) a
Age >75 4.69 (4.27–5.16) a 6.63 (6.11–7.20) a
More than 4 years post primary PCI
Age 56–65 1.27 (0.95–1.70) 1.95 (1.71–2.24) a
Age 66–75 1.72 (1.30–2.27) a 3.60 (3.18–4.08) a
Age>75 1.66 (1.15–2.41) a 9.73 (8.65–10.94) a
Sex
Male (reference) 1.00 1.00
Female 1.33 (1.26–1.41) a 1.16 (1.12–1.21) a
Calendar year
2005–2007 (reference) 1.00 1.00
2008–2010 1.00 (0.89–1.10) 1.02 (0.96–1.10)
2011–2013 1.03 (0.93–1.15) 1.11 (1.03–1.19)
Medical history
Diabetes 1.58 (1.47–1.69) a 1.45 (1.38–1.52) a
Renal Failure 2.52 (2.27–2.81) a 2.25 (2.07–2.45) a
Pre procedural ventilation 3.82 (3.56–4.12) a 3.36 (3.15–3.58) a
Pre procedural cardiogenic shock 6.10 (5.72–6.50) a 3.73 (3.55–3.91) a
Presence of LMS stenosis (>50%) 1.67 (1.54–1.81) a 0.50 (0.47–0.52) a
Previous MI 1.52 (1.40–1.65) a 1.50 (1.42–1.58) a
Previous PCI 0.67 (0.60–0.75) a 0.75 (0.70–0.81) a
Family history of CAD 0.75 (0.69–0.81) a 0.78 (0.74–0.816) a
Number of stents
No stents (reference) 1.00 1.00
    1 0.38 (0.35–0.41) a 0.50 (0.47–0.52) a
    2 0.41 (0.38–0.45) a 0.51 (0.48–0.54) a
    3 0.46 (0.42–0.50) a 0.56 (0.52–0.60) a
Arterial access
Femoral (reference) 1.00 1.00
Radial 0.70 (0.63–0.71) a 0.78 (0.75–0.82) a
a

Statistically significant at 5% level